Lena Jendeberg
Directeur/Membre du Conseil chez ATTANA AB
Postes actifs de Lena Jendeberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
ATTANA AB | Directeur/Membre du Conseil | 01/01/2018 | - |
Historique de carrière de Lena Jendeberg
Anciens postes connus de Lena Jendeberg
Sociétés | Poste | Début | Fin |
---|---|---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Corporate Officer/Principal | 01/01/2016 | - |
Formation de Lena Jendeberg
Royal Institute of Technology | Doctorate Degree |
Statistiques
Internationale
Suède | 4 |
Opérationnelle
Corporate Officer/Principal | 1 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Health Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ATTANA AB | Health Services |
Entreprise privées | 1 |
---|---|
Modus Therapeutics AB
Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Health Technology |
- Bourse
- Insiders
- Lena Jendeberg
- Expérience